I am a
Home I AM A Search Login

Papers of the Week

2021 Aug

J Gastrointest Oncol



The expression and prognostic value of REXO4 in hepatocellular carcinoma.


Chen W, Gao C, Shen J, Yao L, Liang X, Chen Z
J Gastrointest Oncol. 2021 Aug; 12(4):1704-1717.
PMID: 34532121.


Globally, one of the dominant causes of cancer-related mortality is liver cancer. Identification of potent biomarkers for initial stage diagnosis and prognosis is a key factor to ensure efficient therapy and reduce the mortality rate in liver cancer patients. REXO4 has been reported in neuropathic pain and familial isolated pituitary adenoma (FIPA), however, its relationship with liver cancer is still elusive.